Thromboembolism, on the other hand, can be difficult to diagnose in the elderly people because of the large number of alternative cardiopulmonary conditions that can mimic PE.
Methods

Patients
We considered a group of consecutive patients with suspected PE who visited the Emergency Department (ED) of Ospedale Maggiore Policlinico, Milan. All T he incidence of venous thromboembolism and its complications increases with age 1 : 1 case per 1 000 000 children aged <15 years; 72.4 cases per 100 000 adults aged 40 to 54 years; and 280 cases per 100 000 person who are from 85 to 89 years of age. 2, 3 Autopsy series have shown that pulmonary embolism (PE) is responsible for, or at least accompanies, 12% of all in-hospital deaths, and this increases to 20% in the case of patients ≥70 years of age [4] [5] [6] ; furthermore, it is also associated with greater mortality among the elderly patients than the younger patients. 7, 8 The influence of age on predisposing factors, diagnostic tests, and clinical presentation of pulmonary embolism was evaluated in 582 subjects with suspected pulmonary embolism (180 aged <65 years; 402 aged ≥65 years) consecutively enrolled at the Emergency Department. Pulmonary embolism was confirmed in 40% of patients, 75% of those were aged >65 years. Age was directly related to the diagnosis, and the observed probability was higher than the expected probability in the 70 to 79 year subgroup. Score at the Cumulative Illness Rating Scale significantly increased as a function of both age and pulmonary embolism. Dyspnea, syncope, jugular distension, and history of previous venous thromboembolism were more frequently observed in elderly patients. In-hospital mortality rate among the elderly and younger patients was 2% and 0.2%, respectively. The authors conclude that age ≥65 years and high comorbidity are risk factors for pulmonary embolism. Keywords: pulmonary embolism; thromboembolism; clinical probability; spiral computed tomography; age groups patients were evaluated to confirm or rule out venous thromboembolism. All patients or their relatives agreed with this study.
First-Level and Second-Level Evaluation
First-level evaluation included complete history, physical examination, D-dimer plasma level measurement (Instrumentation Laboratory Company, Lexington, Massachusetts), chest X-ray, 12-lead electrocardiography, and arterial blood gas analysis.
Comorbidity was measured using the Cumulative Illness Rating Scale (CIRS), which takes into account the number of medical problems and weighs them based on their severity to generate an accurate assessment of patient's health. We used the modified version of Miller et al, 11 which considers 14 body systems or organs (cardiac, vascular, hematological, respiratory, otorhinolaryngological or ophthalmological, upper gastrointestinal, lower gastrointestinal, hepatic or pancreatic, renal, genitourinary, musculoskeletal or tegumental, neurological, endocrine or metabolic, or breast, and psychiatric) using a 5-point scale (1 = no problem; 2 = minor current problem or significant history; 3 = morbidity or moderate discomfort; 4 = severe problem; and 5 = extremely severe problem requiring immediate treatment: organ failure or severe functional impairment).
All of the patients underwent a pretest probability evaluation for PE using the scoring criteria proposed by Wells et al. 12 Pulmonary embolism was ruled out in the case of a low pretest probability and negative D-dimer test, and no further diagnostic investigations were undertaken. However, a clinical follow-up at 3 months was carried out, which is given below.
The patients with a moderate or high clinical probability of PE, as well as those with a low probability but positive D-dimer test underwent secondlevel instrumental evaluation for 30 to 120 minutes after admission in the ED. It consisted of a 4-slice spiral computed tomography with or without venousphase imaging (sCT; Light Speed, GE, Wisconsin) or a lung perfusion scan (only selected cases underwent both pulmonary perfusion and ventilation scintigraphy) with an addition of a lower limb venous compression ultrasonography (CUS). The diagnostic criterion for deep-vein thrombosis (DVT) in CUS was popliteal or femoral veins noncompressibility.
All of the hemodynamically unstable subjects underwent complete 2-dimensional and Doppler echocardiography within 24 hours of the diagnosis of PE, with visual assessment of right ventricular dilatation and systolic dysfunction, and abnormal septal motion or deviation. Continuous-wave Doppler recordings of tricuspid regurgitation were obtained using the parasternal, apical and subcostal views, and Doppler-derived systolic pulmonary artery pressure was calculated from the peak tricuspid regurgitant velocity using Bernoulli's equation. 13 The diagnostic criteria for PE were: 1) partial or total filling defects in pulmonary circulation, documented by multislice sTC; 2) perfusion lung scan-revealed segmental or subsegmental defects, associated with abnormal CUS demonstrating DVT; and 3) a high-probability ventilation perfusion lung scan. None of the study patients was diagnosed as having PE by means of conventional pulmonary angiography. The absence of PE was diagnosed in the case of one of the following: 1) a normal lung scan; 2) a D-dimer level of <500 µg/L, accompanied by a low clinical probability of PE; or 3) negative sCT. A 3 months follow-up was carried out for all patients in whom PE was ruled out to record the occurrence of any venous thromboembolic event.
The patients were retrospectively divided into 2 groups based on whether their age was <65 or ≥65 years. First-level evaluation, the outcome of diagnostic tests, and in-hospital mortality of each group were compared. Patients were also divided into age subgroups of <40, 40 to 49, 50 to 59, 60 to 69, 70 to 79, and >80 years to compare the observed and expected frequency of PE in each subgroup.
Statistical Analysis
Unless stated otherwise, the between-group differences were evaluated using the nonparametric Wilcoxon-Mann-Whitney U and chi-square (χ 2 ) tests. A P value of <.05 was considered statistically significant.
Results
Prevalence of PE by Age
Between January 2002 and December 2005, 582 patients with suspected PE were seen in our ED, 180 of whom were <65 years old and 402 were ≥65. The diagnosis of PE was confirmed in 233 cases. The median age of the patients with PE was 71.7 ± 15.3 years, the median age of those without PE was 66.8 ± 17.7 years (P < .001). Pulmonary embolism was confirmed in 57 cases in the group of <65-yearold patients, (29 females 50.9% and 28 males 49.1%, with a mean age ± SD of 49.46 ± 11.53 years) for a PE prevalence of 31.6%, and 176 cases in the group aged ≥65 years (98 females 55.7% and 78 males 44.3%, with a mean age of 78.9 ± 7.15 years), for a PE prevalence of 43.7%. A χ 2 test showed a significant association between the age of the patients and the probability of presenting PE (χ 2 (1) = 7.60, P < .007), with the probability being significantly higher in the elderly patients. Analysis of the age subgroups showed that the observed probability of a diagnosis of PE exceeded the expected probability in the 70 to 79 year subgroup ( Figure 1 ). Table 1 shows that clinical presentation of PE was similar in younger (<65 years) and elderly (≥65 year) patients, but there was a significant positive association between age and dyspnea. However, syncope (defined as a sudden, transient loss of consciousness with an inability to maintain postural tone and spontaneous recovery) was more likely to be a presentation symptom in the elderly patients. Chest pain was more likely to be reported by younger than elderly patients, whereas jugular distension was more frequent in elderly patients.
Clinical Presentation
Blood pressure, heart rate, and arterial gases. There were no significant differences in systolic and diastolic pressure or heart rate between the 2 patient groups with diagnosis of PE.
In terms of arterial gases, a t test analysis revealed that arterial pO 2 tension and arterial O 2 saturation were significantly higher in the younger patients and the alveolar-arterial difference were statistically higher in the elderly patients with confirmed PE ( Table 2) . Table 3 show the statistically relevant risk factors for venous thromboembolism, recorded in ED. There was a significant association between PE and malignancies among the younger patients, whereas the association between PE and cancer among elderly patients was marginally significant, suggesting a trend in the specified direction. Pulmonary embolism and previous thromboembolism were significantly associated only among the elderly patients. On one hand, orthopedic surgery was marginally associated with PE in elderly patients, whereas general surgery was not. On the other hand, we observed a tendency toward an association between general (not orthopedic) surgery and PE in younger patients.
Risk factors.
Clinical Probability
The pretest clinical probability scores in the 2 age groups are shown in Table 4 . Figure 2 shows the prevalence of PE in patients with different pretest probability in young and elderly patients. Statistical analysis showed that the ability of Wells clinical scores to predict the probability of clinically confirmed PE was not different in the 2 age groups, and multivariate analysis (MANOVA) showed that clinical scores tend to increase with age (F 1,578 = 3.18; P < .08), regardless of the final diagnosis.
Comparative Study on the Impact of Aging Population/ Castelli et al 67 D-dimer plasma level measurement. The overall sensitivity of D-dimer levels was 0.98, and the overall specificity was 0.31. There were 2 false-negative results among the 233 patients with a diagnosis of PE: 1 in a patient aged ≤65 years and the other in a patient aged >65 years. Sensitivity was excellent in both the younger and the elderly patients (0.94 and 0.99, respectively), whereas specificity was age dependent (0.57 and 0.16).
Second-level evaluation. On the whole, 446 patients were studied in the ED with sCT, whereas 106 patients were studied with lung perfusion scan or ventilation perfusion (V/P) lung scan. Moreover, perfusion lung scan was performed in 105 cases with sCT proven PE, as a reference test for followup. Thirty patients did not undergo second-level evaluation because of a low pretest probability and a negative D-dimer test; the absence of venous thromboembolism was confirmed in these cases by 3 months follow-up. Spiral computed tomography was diagnostic tool for PE in 50 patients aged <65 years and in 160 patients aged ≥65. The test was negative for PE in 62 and 163 patients who are <65 and ≥65 years, respectively. In two <65-year-old patients and three ≥65-year-old patients with negative sCT, PE was proved by positive lung scan and venous CUS. Thromboembolism was reported at 3 months followup in a 73-year-old woman who had a negative CT scan in the first visit. In 11 patients (3 aged <65 and 8 aged ≥65), the result of sCT was uncertain: venous thromboembolism was demonstrated by CUS or (V/P) lung scan in 3 cases, it was ruled out by normal perfusion scan in the remaining 8 cases. sCT provided an alternative diagnosis to PE in 29 elderly patients (pneumonia in 20 patients, cancer in 7, pneumothorax in 1, and aortic dissection in 1) and in 17 younger patients (pneumonia in 15, cancer in 2).The proportion of patients with and without PE in the 2 age groups is reported in the first section of Results.
Venous phase sCT or CUS were performed in 288 patients. In patients with PE, DVT was demonstrated by sCT in 26 of 37 (70%) younger patients, and in 74 out of 117 (63%) elderly patients; ultrasonography showed DVT in 16 (57%) of 28 younger patients and in 39 (51%) of 76 patients aged ≥65. Both exams were performed in 41 patients: in conclusion, DVT was documented in 36 out of 57 (68%) younger patients and in 105 out of 160 (65%) elderly patients with PE. Deep vein thrombosis was also observed in 9 patients (8 of whom aged ≥65 and one aged <65) with PE excluded by sCT and perfusion lung scan. ED was intravenous unfractionated heparin or subcutaneous low molecular weight heparin (LMWH). None of patients was treated with caval filters and 14 received a thrombolytic treatment. Oral anticoagulation was generally started within 24 hours of the diagnosis, and the mean duration of heparin administration was 6 ± 3 days. Major bleeding complications arose in 9 (5.1%) patients aged ≥65 years and in 3 (5.2%) aged <65 years. A total of 13 patients with PE (5.57%) died in hospital. This number included 11 patients aged ≥65 years (6.25%) and 2 aged <65 years (3.5%); the in-hospital mortality rate among the elderly and younger patients were 2% and 0.2%, respectively.
Discussion
The relevance of age on clinical presentation and risk factors was evaluated in 582 subjects admitted to ED for suspected PE.
In accordance with previous reports, 1,2,16 we found a significant association between age and the probability of presenting PE, which was significantly higher in the patients aged ≥65 years. The prevalence of PE was 31.6% in the patients aged <65 and 43.7% in the elderly patients. Furthermore, 75% of the patients with PE were aged ≥65 years. We also divided our study population into age categories to establish the age at which the observed probability of PE exceeds the expected probability, which was found to be 70 to 79 years (Figure 1 ).
Recent studies have begun to clarify the association between aging and venous thrombosis. [17] [18] [19] Agerelated changes occur in the vascular and hemostatic system, affecting platelet activity, coagulation factors, and coagulation inhibitors, as well as the endothelium. [20] [21] [22] The fibrinolytic system is also impaired by aging, as is shown by increased levels of plasminogen activator inhibitor 1, which positively correlate with age-related pathological conditions such as diabetes, insulin resistance, and atherosclerosis. [23] [24] [25] Advanced age is also accompanied by vessel stiffness and dilatation due to the degeneration of elastic fibers and increased collagen content and associated with a reduced expression of nitric oxide synthase thus leading to reduced NO production, which may contribute to platelet activation and thrombosis. 26, 27 Hypercoagulability and vascular wall changes together may increase the incidence of thrombotic events and pulmonary thromboembolism in the elderly patients.
We found a significant correlation of CIRS score, which represent the clinical burden of multiple medical problems, with the diagnosis of PE. This finding is supporting the hypothesis that elevated comorbidity could be a major cause of the high incidence of PE in the elderly patients. [28] [29] [30] [31] With regard to other well-known risk factors, there was a significant relationship between cancer and PE in our younger patients, but not in the elderly group. In contrast, history of previous PE or DVT was statistically related to PE in the elderly patients, but not in the younger ones (Table 3) . Orthopedic (but nongeneral) surgery, although not statistically significant, preceded PE in a number of elderly patients, despite standard LMWH prophylaxis. This finding indicates that additional prophylactic measures, such as pneumatic compression and early postoperative physiotherapy, should be recommended in this high-risk population. The other risk factors were equally distributed in the different age groups regardless of the presence or absence of PE. The differences in the studied populations, such as whether hospitalized or not and different comorbidity level, could be at the base of the contrasting data about risk factors reported in the literature. Punukollu et al 32 found that only immobilization was more frequently associated with PE in elderly patients, whereas Kokturk et al 33 could not find any significant differences between younger and elderly patients in terms of risk factors.
The high incidence of PE in elderly patients and the 10-fold higher in-hospital mortality rates in this group of patients compared with the younger group require physicians to maintain a high level of suspicion to make a prompt diagnosis and initiate an appropriate treatment. Furthermore, the atypical presentation could make the diagnosis of PE difficult in advanced age 34 ; in fact, hemoptysis and chest pain were reported by few of our elderly patients with PE. The less frequent occurrence of chest pain in the elderly patients may be due to the diminished visceral pain sensitivity and perception of these patients. [34] [35] [36] In line with the results of previous studies, 33, 37, 38 syncope and dyspnea were more frequent in patients aged ≥65 (Table 1) , together with lower oxygenation indexes ( Table 2) . A worse respiratory picture in our elderly patients may be the consequence of preexisting pathological conditions, such as chronic obstructive pulmonary disease or congestive heart failure. However, these conditions were equally distributed in both of our PE patient groups. A number of causes could explain the higher incidence of syncope in this group of patients, including reduced cardiopulmonary reserve and age-dependent sinoatrial node impairment. [39] [40] [41] [42] [43] [44] [45] Considering the relatively high frequency of this symptom in elderly patients with PE, syncope should be ground for suspicion of thromboembolism, especially when otherwise unexplained.
Our data show that the elderly patients with PE have a substantial comorbidity, have, frequently, lack of obvious risk factors for venous thromboembolism (except the advanced age itself), and may have atypical patterns of presentation. A careful diagnostic approach is therefore essential. The first recommended step is to identify the patients with a low, intermediate, or high probability of being affected by PE. Righini et al 46 have demonstrated that assessing clinical probability by a standardized score is useful also in elderly patients. Multivariate analysis showed that our PE patients had higher probability scores than those in whom the diagnosis was ruled out. However, scores increase with age regardless of whether the diagnosis of PE was confirmed or not. In our series, Wells' score seemed to be reliable in all age groups and predictive of the prevalence of PE. D-dimer test has been useful to rule out PE in a minority of elderly patients with low probability score. As a fact, the overall sensitivity of D-dimer test was high in all age groups, but its specificity markedly decreased in advanced age patients. A significant decrease in the specificity (and hence clinical usefulness) of D-dimer concentrations in the elderly patients has been already observed in other studies and could be attributed to age-related comorbidity like neoplasm's, inflammation, infections, or cardiopulmonary disease, as well as to age itself. [47] [48] [49] [50] Our study has some limitations. It is a retrospective comparison of 2 groups of patients divided based on age. Its findings can only be applied to outpatients with suspected PE referred to an ED and not to hospitalized patients.
In conclusion, our study shows that 75% of the PE patients observed in the ED of an urban teaching hospital are aged ≥65 years, indicating that this age subgroup has a high probability of PE. Both age and comorbidity index are directly related to the risk of thromboembolism. The clinical features of PE in elderly patients are more frequently characterized by syncope and dyspnea than in younger patients. In many cases, advanced age itself, as well as previous thromboembolism, orthopedic surgery, and malignancies were the main risk factors. In-hospital mortality is higher in elderly patients.
